Newsfiscal.ai
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway
· Published
Article summary
Scinai Immunotherapeutics CEO Amir Reichman issued a shareholder letter detailing growth in the company's CDMO business and an extended operating runway following recent financing.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…